Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald Pauli currently holds 39,614 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald Pauli has been a net buyer of SGNT stock. They have purchased $11.2K and sold $0 worth of shares.
Ronald Pauli's most recent insider trade was on May 2, 2019, when they sold 15,320 shares at $0.00 per share.
Ronald Pauli serves as Executive at Sagent Pharmaceuticals, Inc. (SGNT). They have executed 10 insider transactions totaling $11.2K over their tenure at the company.
Ronald Pauli holds the position of Executive at Sagent Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ronald Pauli has shown a buying trading pattern, with $11.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ronald Pauli was on May 2, 2019, when they sold $156.3K worth of HZNP shares. This transaction involved 6,014 shares at $25.99 per share.
Ronald Pauli currently owns 39,614 shares of Sagent Pharmaceuticals, Inc. (SGNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald Pauli's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald Pauli has 10 Form 4 filings on record as an insider at Sagent Pharmaceuticals, Inc..
Set alerts for Ronald Pauli and 40,000+ other insiders.